Growth regulation of bovine retinal pericytes by transforming growth factor-β2 and plasmin

Current Eye Research

Volumn 20, Issue 3, 2000, Pages 166-172

  Katsura, Mari ^a,b   Mishima, Hiromu K ^a   Minamoto, Atsushi ^a   Ishibashi, Fukashi ^c   Yamashita, Hidetoshi ^d  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b TSUCHIYA GENERAL HOSPITAL   (Japan)

^c Ishibashi Clinic   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

Author keywords

Bovine (cattle); DNA synthesis; Plasmin; Retinal pericyte; Transforming growth factor 2 (TGF 2)

Indexed keywords

APROTININ; DNA; GLUCOSE; NEUTRALIZING ANTIBODY; PEPTIDASE; PLASMIN; PROTEINASE INHIBITOR; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA2; TRITIUM;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CATTLE; CELL CULTURE; CELL CYCLE; CELL GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA CELL;

EID: 0034033684     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200003)2031-9FT166     Document Type: Article

References (39)

1. Shepro D, Morel NML. Pericyte physiology. FASEB J. 1993;7:1031-1038.
2. Diaz-Flores L, Gutierrez R, Verela H, Varela H, Rancel N, Valladares F. Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopathol. 1991;6:269-286.
3. Kuwabara T, Cogan DG. Studies of retinal vascular patterns. Arch Ophthalmol. 1960;64:904-911.
4. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol. 1989;109:309-315.
5. Rhodin JAG, Fujita H. Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analyses. J Submicrosc Cytol Pathol. 1989;21: 1-34.
6. D'Amore PA, Smith SR. Growth factor effects on cells of the vascular wall: a survey. Growth Factors. 1993;8: 61-75.
7. Yamashita H. Functions of the transforming growth factor-beta superfamily in eyes. J Jpn Ophthalmol Soc. 1997;101:928-947.
8. Rifkin DB, Gleizes PE, Harpel J. Plasminogen / plasminogen activator and growth factor activation. Ciba Found Symp. 1997;212:105-115.
9. Hahn B, Knorr M, Wunderlich K, Dartsch PC. Growth characteristics of bovine retinal pericytes in culture. Ophthalmologe. 1994;91:368-372.
10. Yamagishi S, Hsu C, Kobayashi K, Yamamoto H. Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochem Biophys Res Commun. 1993;191:840-846.
11. Jackson JA, Carlson EC. Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine. Am J Physiol. 1992;263:H634-H640.
12. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
13. Gitlin JD, D'Amore PA. Culture of retinal capillary cells using selective growth media. Microvasc Res. 1983;26: 74-80.
14. Wong HC, Boulton M, Marshall J, Clark P. Growth of retinal capillary endothelia using pericyte conditioned medium. Invest Ophthalmol Vis Sci. 1987; 28:1767-1775.
15. Capetandes A, Gerritsen ME. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci. 1990; 31:1738-1744.
16. Herman IM, D'Amore PA. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol. 1985;101: 43-53.
17. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest. 1973;52:2757-2764.
18. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. Heterogeneity in localization of isoforms of TGF-? in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci. 1993;34:477-487.
19. Pfeffer BA, Flanders KC, Guerin CJ, Danielpour D, Anderson DH. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res. 1994;59:323-333.
20. Ie D, Gordon LW, Glaser BM, Pena RA. Transforming growth factor-beta 2 levels increase following retinal laser photocoagulation. Curr Eye Res. 1994;13:743-746.
21. Connor TB, Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, Bustros S, Enger C, Kato H, Lansing M, Hayashi H, Glaser BM. Correlation of fibrosis and transforming growth factor-beta type2 levels in the eye. J Clin Invest. 1989;83(5), 1661-1666.
22. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft, RA, Franks WA, Chignell AH, Dumonde DC. (1991) Cytokines in proliferative vitreoretinopathy. Eye. 1991;5: 686-693.
23. Asrar AMAE, Maimome D, Morse PH, Gregory S, Reder AT. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 1992;114:731-736.
24. Hirase K, Ikeda T, Sotozono C, Nishida K, Sawa H, Kinoshita S. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy. Arch Ophthalmol. 1998;116:738-741.
25. Kishi H, Mishima HK, Yamashita Y. Effect of Cytokines and prostaglandins on the growth of chick retinal pigment epithelial cells. Curr Eye Res. 1994;13: 833-837.
26. Thieler H, Anger G. Comparative quantative urinary protein determination by means of the biuret method and Lowry's copper-Folin reaction. Klin Wochenschr. 1966; 44:464-467.
27. Dosso AA, Brooks RA, Beltramo E, Molinatti PA, Kanse SM, Kohner EM, Porta M. A study of the effects of human blood derivatives and individual growth factors on 3H thymidine uptake in bovine retinal pericytes and endothelial cells. Acta Diabetol. 1993;30:207-213.
28. Taipale J, Koli K, Keski-Oja J. Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem. 1992;267:25378-25384.
29. Lamarre J, Vasudevan J, Gonias SL. Plasmin cleaves betaglycan and releases a 60kDa transforming growth factor-β complex from the cell surface. Biochem J. 1994; 302:199-205.
30. Neveu I, Jehan F, Jandrot-Perrus M, Wilon D, Brachet P. Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: A possible involvement of thrombin. J Neurochem. 1993;60:858-867.
31. Herbert J, Lamarche I, Carmeliet P. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J Biol Chem. 1997;272:23585-23591.
32. Tang H, Kerins DM, Hao Q, Inagami T, Vaaghan DE. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen activated protein kinase in cultured endothelial cells. J Biol Chem. 1998;273: 18268-18272.
33. Broder CC, Lottenberg R, von Mering GO, Johnston KH, Boyle MD. Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem. 1991;266(8):4922-4928.
34. Lottenberg R, Broder CC, Boyle MD, Kain SJ, Schroeder, BL and Curtiss R. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol. 1992;174(16):5204-5210.
35. Burtin P, Fondaneche MC. Solubilization of the plasmin receptor from human carcinoma cells. Biochem Biophys Res Commun. 1990;170(2):748-754.
36. Becquemont L, Nguyen G, Peraldi MN, He CJ, Sraer JD, Rondeau E. Expression of plasminogen/plasmin receptors on human glomerular epithelial cells. Am J Physiol. 1994;267:F303-310.
37. Winram SB, Lottenberg R. The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology. 1996; 142:2311-2320.
38. Pollanen J. Down-regulation of plasmin receptors on human sarcoma cells by glucocorticoids. J Biol Chem. 1989;264(10):5628-5632.
39. Hall SW, Humphries JE, Gonias SL. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alfha 2-macroglobulin. J Biol Chem. 1991;266(19): 12329-12336.